Gsk
Gsk News
Unilever to lay off 1,500 employees after failed GSK-Pfizer unit takeover bid
The announcement comes after Unilever failed with a $68-billion takeover bid for the consumer health care unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer
GSK, Vir Bio's COVID-19 antibody treatment can reduce hospitalisation, deaths
They announced the results of the study, pending online publication, that demonstrates the efficacy of VIR-7831 against variants of concern from the UK, South Africa and Brazil.
GSK, CureVac band together to develop vaccine that will target new COVID-19 mutations
Health officials around the world are raising concerns about new virus variants that are more contagious or resistant to existing vaccines.
Sanofi-GSK COVID-19 vaccine delayed till end of 2021 after interim results show low immune response in older adults
The companies plan a Phase 2b study expected to start in February. If the data is positive, a global Phase 3 study could start in the second quarter of next year
Cipla submits application with USFDA for generic version of asthma drug
Drug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK's Advair Diskus, which is used in the treatment of asthma and other respiratory disorders
Sensex plunges over 800 points, Nifty slumps 227 points in early trade as economic package fails to impress
After hitting a low of 30,265.67, the Sensex was trading 731.91 points or 2.35 percent lower at 30,365.82. Similarly, NSE Nifty slumped 226.90 points, or 2.48 percent, to 8,909.95.
GSK exits HUL, offloads 5.7% stake for Rs 25,480 cr in largest block trade ever carried out in Indian equity market
On 1 April 2020, GSK had announced the completion of its divestment of its popular healthcare drink brand Horlicks and other consumer healthcare nutrition products in India to Unilever.
CCI approves GlaxoSmithKline, Pfizer consumer healthcare joint venture
The Competition Commission on Friday said it has approved the formation of a joint venture for consumer healthcare products by pharmaceutical giants GlaxoSmithKline (GSK) and Pfizer
Pfizer to shut down two plants in India citing unviability; decision leaves about 1,700 employees in lurch
Pfizer will soon shut down its plants in Aurangabad, Maharashtra and Irungattukottai (IKKT) near Chennai in Tamil Nadu citing lack of viability.
GSK and Pfizer to combine consumer health businesses; British drugmaker plans to split into two businesses
GSK said the deal laid the foundation for the creation of two new UK-based global companies focused on pharmaceuticals/vaccines and consumer healthcare
Energy shot for HUL: Will buyout of GSK's Horlicks, Boost brands work wonders for the consumer giant?
At first glance, this deal looks expensive from the point of view of HUL, but the acquisition of Boost, Viva and Maltova would significantly boost its foods and refreshment business, going forward.
GSK Consumer Healthcare says it is considering potential transaction of nutrition business; Unilever confirms development
Hindustan Unilever, the Indian arm of Unilever, confirmed that the company was in the race to acquire GlaxoSmithKline Plc's consumer healthcare nutrition products
Study of genes uncovers secrets of parasitic worms and new ways to treat infections
The study offers the best insight yet into parasite biology & how they evade our immune systems.
Coca-Cola in race to buy Horlicks from GlaxoSmithKline, value of transaction could be around $3.9 billion
Besides Coca-Cola, several global FMCG makers as Nestle, Kraft Heinz are in the race to acquire Horlicks from GSK
GSK seeks mid-September bids for $4 billion Indian Horlicks unit, say sources
GSK started a strategic review of Horlicks - a malt-based drink brand popular in India – and some smaller products, after buying Novartis out of their consumer healthcare venture for $13 billion in March.
GSK to access DNA data from millions by partnering with Google-funded 23andMe
With more than 5 million customers, 23andMe has a trove of information about the links between genes and disease.
GSK to sell Horlicks to fund $13 bn Novartis deal; Nestle, Kraft, Unilever likely suitors, say sources
GSK has started a strategic review of Horlicks - a malt-based drink brand popular in India – and some of its smaller products, after buying Novartis out of their consumer healthcare venture for $13 billion on Tuesday.
Facebook is closely working with marketers and advertisers to drive business growth in India
With 2.1 billion monthly active users globally, Facebook currently has 212 million monthly active users on smartphones in India.
Compat overrules CCI's Rs 64 crore fine imposed on GlaxosmithKline, Sanofi
The tribunal's order comes more than a year after the CCI had slapped Rs 64 crore fine on the two firms for alleged collusive bidding in supply of a meningitis vaccine to the government for Haj pilgrims
Hunt for AIDS cure accelerates as GSK and US experts link up
Britain's GlaxoSmithKline , which decided last week to retain rather than float off its HIV drugs business, is to collaborate with U.S. scientists in developing a cure for AIDS.